EUVIMEDObjevte EUVIMED
Crossref

Plasma pharmacokinetics of adriamycin after intrapleural administration

S Eksborg, A Lindfors, B J Cedermark

Medical Oncology and Tumor Pharmacotherapy · 1984

DOI: 10.1007/bf02934140 ↗

At a glance

Journal article in Medical Oncology and Tumor Pharmacotherapy, 1984. Written by S Eksborg and 2 co-authors. Cited 4 times so far (Crossref); 16 references.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

The plasma pharmacokinetics of adriamycin after intrapleural administration have been studied. The maximum plasma concentration found after intrapleural instillation of 50 mg was 100 ng ml-1, the adriamycin half-life being about 2.5 h. Large amounts of the drug are adsorbed from the pleura. Hence risks for cardiomyopathy, previously associated with the repeated intravenous administration of adriamycin, must also be considered after intrapleural administration.

Subjects

MeSH terms (MEDLINE)

DoxorubicinHumansKineticsPleuraPleural Effusion

Substances

Doxorubicin

Cite

APA

Eksborg, S., Lindfors, A., & Cedermark, B. J. (1984). Plasma pharmacokinetics of adriamycin after intrapleural administration. Medical Oncology and Tumor Pharmacotherapy. https://doi.org/10.1007/bf02934140

Vancouver

Eksborg S, Lindfors A, Cedermark BJ. Plasma pharmacokinetics of adriamycin after intrapleural administration. Medical Oncology and Tumor Pharmacotherapy. 1984. doi:10.1007/bf02934140

BibTeX
@article{Eksborg1984,
  author = {Eksborg, S and Lindfors, A and Cedermark, B J},
  title = {Plasma pharmacokinetics of adriamycin after intrapleural administration},
  journal = {Medical Oncology and Tumor Pharmacotherapy},
  year = {1984},
  doi = {10.1007/bf02934140}
}
Start for free →